Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Neoplasm of Head and Neck”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT03781986
What this trial is testing

APG-115 in Salivary Gland Cancer Trial

Who this might be right for
Malignant Salivary Gland CancerSalivary Gland Cancer
University of Michigan Rogel Cancer Center 41
Testing effectiveness (Phase 2)Study completedNCT03356223
What this trial is testing

Evaluation of ABEMACICLIB Monotherapy in Patients With Locally Advanced/Metastatic Head and Neck Cancer After Failure of Platinum and Cetuximab or Anti-EGFR-based Therapy and Harboring an Homozygous Deletion of CDKN2A, and/or an Amplification of CCND1 and/or of CDK6

Who this might be right for
Head and Neck CancerAdvanced CancerMetastatic Cancer
Centre Leon Berard 25
Testing effectiveness (Phase 2)Study completedNCT00006361
What this trial is testing

SU5416 in Treating Patients With Advanced or Recurrent Cancer of the Head and Neck

Who this might be right for
Carcinoma of Unknown PrimaryHead and Neck CancerNon-melanomatous Skin Cancer
Memorial Sloan Kettering Cancer Center
Not applicableStudy completedNCT02892786
What this trial is testing

Detection in Peripheral Blood of Circulating Tumor Cells in Patient With Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Cancer
Institut de Cancérologie de Lorraine 40
Early research (Phase 1)Ended earlyNCT04931823
What this trial is testing

Dose Escalation and Dose Expansion Study of CPO-100 in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor
Conjupro Biotherapeutics, Inc. 34
Early research (Phase 1)Study completedNCT01872923
What this trial is testing

Dose Escalating Study for Amphinex-based PCI of Bleomycin.

Who this might be right for
Cutaneous or Sub-cutaneous Malignancies
PCI Biotech AS 3
Not applicableEnded earlyNCT02601079
What this trial is testing

Endodrill vs. Conventional Biopsy. Diagnostics and Genetic Analysis

Who this might be right for
Esophageal Neoplasm
Region Skane 7
Testing effectiveness (Phase 2)Looking for participantsNCT06534762
What this trial is testing

Milaberon in Advanced Solid Tumors: an Open, Multicenter Clinical Study

Who this might be right for
NSCLCSCLCColorectal Cancer+4 more
Zhejiang Provincial People's Hospital 260
Testing effectiveness (Phase 2)Looking for participantsNCT07602842
What this trial is testing

IDP-001 in Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced Solid TumorMetastatic Solid TumorHead and Neck Squamous Cell Carcinoma+6 more
InduPro, Inc. 132
Testing effectiveness (Phase 2)Study completedNCT01065844
What this trial is testing

Nelfinavir in Recurrent Adenoid Cystic Cancer of the Head and Neck

Who this might be right for
Carcinoma, Adenoid CysticHead and Neck Neoplasms
University of Iowa 15
Testing effectiveness (Phase 2)Study completedNCT03691714
What this trial is testing

Durvalumab (MEDI4736) With Cetuximab in Previously Treated Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Who this might be right for
Recurrent Head and Neck CancerHead and Neck CancerHead and Neck Neoplasms+1 more
University of Cincinnati 35
Not applicableUnknownNCT06256809
What this trial is testing

Analyzing Handprint Patterns to Predict Oral Cancer Risks: A Comparative Study

Who this might be right for
Oral Leukoplakia
King Khalid University 160
Early research (Phase 1)WithdrawnNCT02205463
What this trial is testing

KD019 and Trastuzumab in Patients With Esophagus, Gastroesophageal Junction and Stomach Cancer

Who this might be right for
Esophageal CancerStomach Cancer
NYU Langone Health
Not applicableStudy completedNCT03821064
What this trial is testing

Single-arm Phase II Study of NDURE for Patients With HNC

Who this might be right for
Cancer of Head and Neck
Medical University of South Carolina 11
Not applicableStudy completedNCT06256263
What this trial is testing

Stapler Versus Conventional Pharyngeal Repair After Total Larygectomy

Who this might be right for
Malignant Tumor of the Larynx
Mansoura University 58
Early research (Phase 1)UnknownNCT02637531
What this trial is testing

A Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IPI-549

Who this might be right for
Advanced Solid Tumors (Part A/B/C/D)Non-small Cell Lung Cancer (Part E)Melanoma (Part E)+5 more
Infinity Pharmaceuticals, Inc. 219
Early research (Phase 1)Looking for participantsNCT03114462
What this trial is testing

Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer

Who this might be right for
Malignant Neoplasms of Respiratory and Intrathoracic OrgansSquamous Cell Carcinoma of the Larynx
M.D. Anderson Cancer Center 11
Not applicableStudy completedNCT03653039
What this trial is testing

Comparison Between a Standard Tube and the Ultra-thin Tritube for Intubation of the Trachea and for Maintaining Access to the Trachea After Anaesthesia, in Patients With an Expected Difficult Direct Laryngoscopy

Who this might be right for
Oral NeoplasmPharynx CancerLarynx Cancer
Michael Seltz Kristensen 48
Testing effectiveness (Phase 2)Study completedNCT02268695
What this trial is testing

Platinum-Cetuximab Combined With Docetaxel or With 5FU in Patients With Recurrent/Metastatic HNSCC

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Groupe Oncologie Radiotherapie Tete et Cou 541
Not applicableUnknownNCT04117139
What this trial is testing

The Diagnostic Value of PET/MRI in Head and Neck Cancer

Who this might be right for
Squamous Cell Carcinoma of Head and NeckHead and Neck NeoplasmsLymph Node Metastases
Odense University Hospital 142
Next Page